NCT00369018 - A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Cervical Dysplasia

Interventions

DRUG

methyl aminolevulinate (MAL) and hexaminolevulinate (HAL)

MAL 1.2M, HAL 10mM and HAL 40mM solutions for 3 and 12 hours application

Trial Locations (2)

Medizinische Hochschule Hannover, Department of Obstetrics and Gynecology, Hanover

Ullevål University Hospital, Department of Obstetrics and Gynecology, Oslo